Next-generation sequencing of cancer consensus genes in lymphoma

被引：10

作者：

Huellein, Jennifer ^{[1
,2
]}

Jethwa, Alexander ^{[1
,2
]}

Stolz, Tatjana ^{[1
,2
]}

Blume, Carolin ^{[1
,2
]}

Sellner, Leopold ^{[1
,2
,3
]}

Sill, Martin ^{[5
]}

Langer, Christian ^{[6
]}

Jauch, Anna ^{[4
]}

Paruzynski, Anna ^{[1
,2
]}

von Kalle, Christof ^{[1
,2
]}

Schmidt, Manfred ^{[1
,2
]}

Glimm, Hanno ^{[1
,2
]}

Zenz, Thorsten ^{[1
,2
,3
]}

机构：

[1] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, D-69120 Heidelberg, Germany

[2] German Canc Res Ctr, D-69120 Heidelberg, Germany

[3] Univ Heidelberg Hosp, Dept Med 5, Heidelberg, Germany

[4] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Germany

[5] German Canc Res Ctr, Div Biostat, D-69120 Heidelberg, Germany

[6] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

来源：

LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 08期

关键词：

Targeted resequencing; cancer consensus genes; lymphoma; chronic lymphocytic leukemia; CLL; multiple myeloma; CHRONIC LYMPHOCYTIC-LEUKEMIA; MUTATION; INACTIVATION; INHIBITION;

D O I：

10.3109/10428194.2013.796053

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Sensitive identification of mutations in genes related to the pathogenesis of cancer is a prerequisite for risk-stratified therapies. Next-generation sequencing (NGS) in lymphoma has revealed genetic heterogeneity which makes clinical translation challenging. We established a 454-based targeted resequencing platform for robust high-throughput sequencing from limited material of patients with lymphoma. Hotspot mutations in the most frequently mutated cancer consensus genes were amplified in a two-step multiplex-polymerase chain reation (PCR) which was optimized for homogeneous coverage of all regions of interest. We show that targeted resequencing based on NGS technologies allows highly sensitive detection of mutations and assessment of clone size. The application of this or similar techniques will help the development of genotype-specific treatment approaches in lymphoma.

引用

页码：1831 / 1835

页数：5

共 50 条

[41] Next-generation screens for cancer genes.
Adams, David J.
CANCER RESEARCH, 2013, 73 (08)
[42] Analysis of selected genes associated with cardiomyopathy by next-generation sequencing
Szabadosova, Viktoria
Boronova, Iveta
Ferenc, Peter
Tothova, Iveta
Bernasovska, Jarmila
Zigova, Michaela
Kmec, Jan
Bernasovsky, Ivan
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (02)
[43] Using next-generation RNA sequencing to identify imprinted genes
X Wang
A G Clark
Heredity, 2014, 113 : 156 - 166
[44] Using next-generation RNA sequencing to identify imprinted genes
Wang, X.
Clark, A. G.
HEREDITY, 2014, 113 (02) : 156 - 166
[45] Study on pathogenic genes of dwarfism disease by next-generation sequencing
Yang, Lv-Lv
Liang, Shi-Shan
WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (07) : 1600 - 1609
[46] USE OF NEXT-GENERATION SEQUENCING PLATFORMS TO IDENTIFY SCHIZOPHRENIA GENES
Hodgkinson, Colin
SCHIZOPHRENIA BULLETIN, 2011, 37 : 71 - 71
[47] The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
Sujobert, Pierre
Le Bris, Yannick
de Leval, Laurence
Gros, Audrey
Merlio, Jean Philippe
Pastoret, Cedric
Huet, Sarah
Sarkozy, Clementine
Davi, Frederic
Callanan, Mary
Thieblemont, Catherine
Sibon, David
Asnafi, Vahid
Preudhomme, Claude
Gaulard, Philippe
Jardin, Fabrice
Salles, Gilles
Macintyre, Elizabeth
HEMASPHERE, 2019, 3 (01):
[48] Consensus Rules in Variant Detection from Next-Generation Sequencing Data
Jia, Peilin
Li, Fei
Xia, Jufeng
Chen, Haiquan
Ji, Hongbin
Pao, William
Zhao, Zhongming
PLOS ONE, 2012, 7 (06):
[49] Study on pathogenic genes of dwarfism disease by next-generation sequencing
Lv-Lv Yang
Shi-Shan Liang
World Journal of Clinical Cases, 2021, 9 (07) : 1600 - 1609
[50] Using next-generation sequencing to identify novel disease genes
Blaydon, D. C.
Walne, A. J.
Plagnol, V.
van Heel, D. A.
Vulliamy, T.
Kelsell, D. P.
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (04) : 930 - 931

← 1 2 3 4 5 →